Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
- Conditions
- Ulcerative ColitisGastrointestinal DiseaseInflammatory Bowel Disease
- Registration Number
- NCT00073047
- Lead Sponsor
- Facet Biotech
- Brief Summary
The purpose of The PROSPECT Study is to evaluate an investigational medication for the treatment of moderate to severe ulcerative colitis. This study is being conducted at up to 38 clinical research centers in the US, Canada, and Belgium, and is open to male and female patients 12 years and older. Participants in the study will have a number of visits to a research center over a five-month period. All study related care and medication is provided to qualified participants at no cost: this includes all visits, examinations, and laboratory work.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (34)
St. Louis Center for Clinical Research
🇺🇸St. Louis, Missouri, United States
The University of Chicago Hospital
🇺🇸Chicago, Illinois, United States
Long Island Clinical Research Associates
🇺🇸Great Neck, New York, United States
Memphis Gastroenterology Group, P.C.
🇺🇸Memphis, Tennessee, United States
Mount Sinai Medical Center
🇺🇸North Miami Beach, Florida, United States
Medlantic Investigators Network
🇺🇸Annapolis, Maryland, United States
Advanced Medical Research Institute
🇺🇸Anaheim, California, United States
Research Foundation of America
🇺🇸Los Angeles, California, United States
Clinical Research Associates
🇺🇸Hollywood, Florida, United States
Atlanta Gastroenterology Associates
🇺🇸Atlanta, Georgia, United States
Cedar Sinai Medical Center
🇺🇸Los Angeles, California, United States
Physician Office
🇺🇸Jacksonville, Florida, United States
Western Gastroenterology Group
🇺🇸Los Angeles, California, United States
Consultants for Clinical Research
🇺🇸Cincinnati, Ohio, United States
Cleveland Clinic Foundation
🇺🇸Cleveland, Ohio, United States
Oklahoma Foundation for Digestive Research
🇺🇸Oklahoma City, Oklahoma, United States
Nashville Medical Research
🇺🇸Nashville, Tennessee, United States
University of Kentucky Chandler Medical Center
🇺🇸Lexington, Kentucky, United States
GVAMC
🇺🇸Gainesville, Florida, United States
Drug Research Services, Inc.
🇺🇸Metairie, Louisiana, United States
Columbia Gastro Associates
🇺🇸Columbia, South Carolina, United States
New York Center for Clinical Research
🇺🇸Lake Success, New York, United States
University of Pittsburgh Medical Center
🇺🇸Pittsburgh, Pennsylvania, United States
Fletcher Allen Health Care
🇺🇸S. Burlington, Vermont, United States
Richmond GI Research Group
🇺🇸Richmond, Virginia, United States
Digestive and Liver Disease Specialists
🇺🇸Norfolk, Virginia, United States
McGuire DVAMC
🇺🇸Richmond, Virginia, United States
Wisconsin Center for Advanced Research
🇺🇸Milwaukee, Wisconsin, United States
University of Alberta
🇨🇦Edmonton, Alberta, Canada
London Health Science Center
🇨🇦London, Ontario, Canada
Universitair Ziekenhuis Gasthuisberg
🇧🇪Leuven, Belgium
Vancouver General Hospital
🇨🇦Vancouver, British Columbia, Canada
Montreal General Hospital
🇨🇦Montreal, Quebec, Canada
University of North Carolina
🇺🇸Chapel Hill, North Carolina, United States